Molecular Biology of the Cell Call for Nominations: MBC Editor-in-Chief

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


MBC in Press, published online ahead of print December 29, 2003
Mol. Biol. Cell 10.1091/mbc.E03-02-0120

A more recent version of this article appeared on March 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E03-02-0120v1
15/3/1313    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kyttälä, A.
Right arrow Articles by Luzio, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kyttälä, A.
Right arrow Articles by Luzio, J. P.

Submitted on February 28, 2003
Revised on October 20, 2003
Accepted on October 23, 2003

Two Motifs Target Batten Disease Protein CLN3 to Lysosomes in Transfected Non-neuronal and Neuronal cells

Aija Kyttälä1, Gudrun Ihrke1, Jouni Vesa2, Michael J. Schell3, and J. Paul Luzio1*

1 Cambridge Institute for Medical Research and Department of Clinical Biochemistry, University of Cambridge, Hills Road, Cambridge CB2 2XY, UK
2 David Geffen School of Medicine at University of California, Los Angeles, California 90095-7088
3 Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ

* Corresponding author. E-mail address: jpl10{at}cam.ac.uk.

Batten disease is a neurodegenerative disorder resulting from mutations in CLN3, a polytopic membrane protein, whose predominant intracellular destination in nonneuronal cells is the lysosome. The topology of CLN3 protein, its lysosomal targeting mechanism, and the development of Batten disease are poorly understood. We provide experimental evidence that both the N- and C-termini and one large loop domain of CLN3 face the cytoplasm. We have identified two lysosomal targeting motifs which mediate the sorting of CLN3 in transfected nonneuronal and neuronal cells: an unconventional motif in the long C-terminal cytosolic tail consisting of a methionine and a glycine separated by nine amino acids [ M(X)9G] , and a more conventional dileucine motif, located in the large cytosolic loop domain and preceded by an acidic patch. Each motif on its own was sufficient to mediate lysosomal targeting, but optimal efficiency required both. Interestingly, in primary neurons, CLN3 was prominently seen both in lysosomes in the cell body and in EEA1-containing endosomes along neuronal processes. As there are few lysosomes in axons and peripheral parts of dendrites, the presence of CLN3 in endosomes of neurones may be functionally important. Endosomal association of the protein was independent of the two lysosomal targeting motifs.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
S. Codlin, R. L. Haines, J. Jemima, E. Burden, and S. E. Mole
btn1 affects cytokinesis and cell-wall deposition by independent mechanisms, one of which is linked to dysregulation of vacuole pH
J. Cell Sci., September 1, 2008; 121(17): 2860 - 2870.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
O. S. Qureshi, A. Paramasivam, J. C. H. Yu, and R. D. Murrell-Lagnado
Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis
J. Cell Sci., November 1, 2007; 120(21): 3838 - 3849.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. L. Eliason, C. S. Stein, Q. Mao, L. Tecedor, S.-L. Ding, D. M. Gaines, and B. L. Davidson
A Knock-In Reporter Model of Batten Disease
J. Neurosci., September 12, 2007; 27(37): 9826 - 9834.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Piccirillo, I. Palmisano, G. Innamorati, P. Bagnato, D. Altimare, and M. V. Schiaffino
An unconventional dileucine-based motif and a novel cytosolic motif are required for the lysosomal and melanosomal targeting of OA1
J. Cell Sci., May 15, 2006; 119(10): 2003 - 2014.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
G. Salazar, B. Craige, B. H. Wainer, J. Guo, P. De Camilli, and V. Faundez
Phosphatidylinositol-4-Kinase Type II {alpha} Is a Component of Adaptor Protein-3-derived Vesicles
Mol. Biol. Cell, August 1, 2005; 16(8): 3692 - 3704.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kyttala, K. Yliannala, P. Schu, A. Jalanko, and J. P. Luzio
AP-1 and AP-3 Facilitate Lysosomal Targeting of Batten Disease Protein CLN3 via Its Dileucine Motif
J. Biol. Chem., March 18, 2005; 280(11): 10277 - 10283.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Storch, S. Pohl, and T. Braulke
A Dileucine Motif and a Cluster of Acidic Amino Acids in the Second Cytoplasmic Domain of the Batten Disease-related CLN3 Protein Are Required for Efficient Lysosomal Targeting
J. Biol. Chem., December 17, 2004; 279(51): 53625 - 53634.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Luiro, K. Yliannala, L. Ahtiainen, H. Maunu, I. Jarvela, A. Kyttala, and A. Jalanko
Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway
Hum. Mol. Genet., December 1, 2004; 13(23): 3017 - 3027.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Heine, B. Koch, S. Storch, A. Kohlschutter, D. N. Palmer, and T. Braulke
Defective Endoplasmic Reticulum-resident Membrane Protein CLN6 Affects Lysosomal Degradation of Endocytosed Arylsulfatase A
J. Biol. Chem., May 21, 2004; 279(21): 22347 - 22352.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2003 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.